Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa
The Danaher Foundation, supported by Danaher (NYSE:DHR), committed $1 million to support Ebola Bundibugyo outbreak response in the DRC and Uganda.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The Danaher Foundation, supported by Danaher (NYSE:DHR), committed $1 million to support Ebola Bundibugyo outbreak response in the DRC and Uganda. Funds go to Save the Children, IRC and World Food Program USA for infection prevention, community health and food assistance.
Details
News Market Reaction – DHR
On Jun 29, the day this news came out, DHR closed 1.74% below the previous close.
Data tracked by StockTitan Argus for the Jun 29 session.
Key Figures
- Ebola relief commitment
- $1 million
- Danaher Foundation funding for Ebola Bundibugyo response via three NGOs
- Confirmed Ebola cases
- more than 1,000 cases
- Ebola Bundibugyo cases in Democratic Republic of Congo, per WHO
- Series A Notes size
- CHF 119,500,000
- 1.65% Series A senior notes due June 3, 2031
- Series B Notes size
- CHF 137,410,000
- 1.88% Series B senior notes due June 3, 2033
- Series A coupon
- 1.65%
- Interest rate on CHF Series A Notes due 2031
- Series B coupon
- 1.88%
- Interest rate on CHF Series B Notes due 2033
- Short interest
- 1.47%
- Reported short interest as of 2026-05-29
- Director RSU grant
- 680 shares
- Typical RSU award per Danaher director Form 4 filings on 2026-05-19
Historical Context
-
Announcement of date and access details for Q2 2026 earnings call.
-
Masimo, a Danaher company, received FDA 510(k) clearance for AI OIRD detection.
-
Danaher completed acquisition of Masimo, adding AI-enabled monitoring to Diagnostics.
-
Sirius XM to join S&P MidCap 400 as Masimo exits after Danaher acquisition.
-
SCIEX, part of Danaher, announced ZenoTOF platform-wide upgrades and new software.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
ebola bundibugyo medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
The funding will be distributed across the three organizations to enable rapid, flexible response to evolving conditions on the ground. Efforts will focus on critical needs including infection prevention, hygiene support, community-based health services and emergency food assistance— areas where speed and adaptability can directly save lives.
Together, Save the Children, IRC and WFP bring complementary capabilities and deep operational presence to coordinate response efforts in some of the most affected communities. Their combined expertise allows resources to be directed quickly to where they are needed most as the situation continues to evolve.
"The Ebola outbreak is occurring in a highly fragile humanitarian environment, where years of underinvestment and recent global funding cuts have severely weakened health services," said Heather Reoch Kerr, IRC's Country Director for the
"This generous support comes at a critical moment for communities in eastern DRC," said Barron Segar, President and CEO of World Food Program
"The Ebola outbreak is compounding an already dire humanitarian crisis in the DRC," said Greg Ramm, Save the Children's Country Director in the
According to the World Health Organization (WHO), more than 1,000 cases of Ebola Bundibugyo have been confirmed in the
ABOUT EBOLA DISEASE
The Centers for Disease Control (CDC) defines Ebola as a disease caused by an infection with an orthoebolavirus found primarily in sub-Saharan Africa. Orthoebolaviruses can cause serious and often deadly disease, with a mortality rate as high as 80-90 percent. The 2026 Ebola outbreak is driven by the Bundibugyo virus disease (BVD), that causes a severe and often fatal form of Ebola disease. Declared a Public Health Emergency of International Concern by the WHO, the 2026 outbreak is historically the largest known Bundibugyo virus outbreak.
ABOUT THE DANAHER FOUNDATION
The Danaher Foundation is the independent philanthropic arm of Danaher Corporation, a global life sciences and technology innovator. Through partnerships with trusted nonprofit organizations and communities around the world, the Foundation's work reflects Danaher's broader commitment to applying science, innovation, and collaboration to address urgent global needs.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve many of their most complex scientific and clinical challenges—helping move innovations from discovery to delivery faster for patients who depend on them. Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-foundation-commits-1-million-to-ebola-outbreak-relief-efforts-in-central-africa-302812644.html
SOURCE Danaher Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.